Pacific Biosciences of California, Inc. (NASDAQ:PACB) showed P/E ratio of 0
Quarterly Sales and EPS Roundup:
Pacific Biosciences of California, Inc. (PACB) reported sales (ttm) of 96.5 Million, whereas, 5 number of analysts estimated the mean sale of 28.35 million. The analysts estimated sales for the higher end at 29.04 million and lower end at 27.1 million while the year ago reported sale was 30.83 million.
5 number of analysts have estimated the sales of the company for the quarter, analysts estimated mean sale target of 31.27 million while high and low sale targets are estimated at 36 million and 29 million respectively.
Pacific Biosciences of California, Inc. (PACB) reported earning per shares for the quarter ending Aug 02 AMC, whereas, 6 number of analysts estimated the mean EPS at -0.21. The analysts estimated EPS for the higher end at -0.19 and lower end at -0.24 while the year ago reported earnings per share was -0.16.
The company has mean EPS estimate of -0.2 reported by 6 number of analyst for the quarter ending Current Qtr.(Sep2017). The analysts estimated mean EPS at -0.2 while the high and low EPS estimate stand at -0.18 and -0.22 respectively. In contrast to the year ago quarter EPS was at -0.14.
Valuation Ratios of Pacific Biosciences of California, Inc. (PACB) versus the Industry and Sector:
Let’s have a look at some of the important valuation ratios of the Pacific Biosciences of California, Inc. (PACB). These ratios are important while doing valuation of the company or the shares of the company.
Pacific Biosciences of California, Inc. (PACB) the company’s industry has 112.08 P/E and the sector P/E is 33.59. The industry’s and sector’s high P/E for the past year is 72.88 and 44.35 respectively and low P/E ratio for the last 5 years is 21.42 for the industry and 24.57 for the Sector.
Beta is also an important valuation ratio for analyzing the stock of the company, PACB has Beta of 2.17 while its industry and Sector’s beta remains at 0.91 and 0.95 respectively.
Price to Sale ratio of PACB stands at 3.61 while Price to Book Ratio stands at 4.33. Its Price to Cash Flow ratio shows the value of 0, whereas, the industry and sector ratio of Price to Cash Flow ticked at 20.92 and 24.57 respectively.
5 Year Growth Rate Analysis:
Growth rates are very important while analyzing the long term growth and valuation of a certain company.
5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of Pacific Biosciences of California, Inc. (PACB) stands at 21.78 while the industry’s and the sector’s growth for next 5 years ticked at 3.13 and 10.59 respectively.
Pacific Biosciences of California, Inc. (PACB) Trading Statistics:
The company surged 14.38% and closed its last trading session at $3.2. The market capitalization of the company is at $401.25 Million. The stock touched 52-week High of $9.50 on 09/22/16 and 52-week Low of $3.08 on 07/21/17. The stock currently has Weekly Volatility of 6.05% and Monthly Volatility of 5.50%. The Beta for the company stands at 2.16 and its Average True Range (ATR) shows a value of 0.19.